Researchers say they have discovered a new class of antibiotics that could treat drug-resistant ... "Lariocidin has a broad spectrum of action as it is effective against both Gram-positive and ...

Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13 ...

We conducted a systematic review and meta-analysis of published studies to summarize the effect of appropriate antibiotic therapy (AAT) or IAT against gram-negative bacterial infections in the ...

The following is a summary of “WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, ...

2) To phenotypically characterize multi-drug-resistant Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, proteus species, Citrobacter species, Salmonella and Shigella isolated ...

studies with community-acquired Gram-negative infections were included only for the outcomes of length of stay and cost. Patients had to have been given empiric antibiotic therapy prior to the ...

They aimed to determine the clinical effects of delayed initiation of broad-spectrum gram-negative antibiotic therapy among adult inpatients (N=746,880) across 928 US hospitals. Patients who were ...